top of page

Upcoming Free Live Webinars

Menstrual blood PCSIG Webinar Social Square (1200 x 1200 px).png

PCSIG Free Webinar - 17 April 2025
Menstrual blood: the best sampling source you never heard of

Paul D Blumenthal (Professor Emeritus, Obstetrics and Gynecology, Stanford University School of Medicine, SPIRES); Søren Therkelsen (CPO, Qvin); Ridhi Tariyal (CEO, NextGen Jane)
​

Taking advantage of a natural non-invasive biopsy.

Menstrual blood represents an innovative and minimally invasive sample type offering valuable insights for clinical trials and drug development. This webinar explores the biology and physiology of menstrual blood, highlights various practical collection methods including tampons, cups, and pads, and discusses the importance of pre-analytical standardization to ensure consistent, high-quality data.

Featuring case studies from leading innovators Qvin and NextGen Jane, attendees will gain practical knowledge on implementing menstrual blood-based diagnostics and hear first-hand patient testimonials emphasizing real-world applications.

PCSIG Clin Trial Apr2025.png

PCSIG Free Webinar - 30 April 2025
Output from PCSIG a clinical trial – Impact of home blood sampling on recruitment and retention

Robyn Rourick (Senior Director, Outsourcing Portfolio Management, Genentech); Mike Walker (Statistics Consultant, Walker Bioscience); Neil Spooner (Chair and Co-founder, Patient Centric Sampling Interest Group)
​

Learn about the impact of collecting blood samples at home on trial recruitment and participant attitudes to the approach.

Patient centric blood sampling offers an alternative approach for the collection of biological samples in locations away from the clinical setting, such as at home. This webinar describes the outcomes of a cross organizational clinical trial that was designed to examine whether collecting patient centric blood samples at home, compared to the same approach in the clinic, had any impact on the recruitment and retention of trial participants. We will also present data obtained from subject questionnaires on attitudes to these sampling approaches.

Biomarkers of colorectal polyps from at-home collected dried blood spots1200x1200.png

PCSIG Free Webinar - 21 May 2025
Biomarkers of colorectal polyps from at-home collected dried blood spots

Ben Herbert (Chief Scientific Officer, Sangui Bio, Australia)


Pre-cancer, colorectal polyp, biomarker discovery using novel sample preparation and MS from at-home collected blood in Mitra.

Sangui Bio is conducting a colorectal polyp study to identify biomarkers that predict large pre-cancerous polyps. 1400 at-home blood samples have been collected using Mitra. The highest risk group in terms of progression to cancer is those with polyps 10 mm or larger. The control group is defined as polyps 5 mm or smaller, including cases with no detected polyps. The blood samples were analyzed using novel sample preparation and MS. Over 2500 proteins were identified and quantified from each sample and several hundred proteins are significantly different.

Free On Demand Webinars

Saliva_Mar2025.png

PCSIG Webinar On Demand-
Saliva as a Diagnostic Tool for Advancing Accessible Testing 

Alexandra Kitz
(Director of Science, SalivaDirect, Inc.)​

​

Learn how saliva-based testing can improve access to diagnostics, reduce patient and provider costs, and have a positive impact on public health response strategies.

In this webinar, we explore how saliva-based diagnostics can be used to advance accessible and equitable healthcare solutions. We discuss the benefits of non-invasive saliva sampling, its applications in diagnosing both infectious and chronic diseases, and its influence on the diagnostic landscape. Real-world examples are shared to demonstrate how innovative protocols and programs can support testing in LMICs, improve access to care in resource-limited settings, reduce patient and provider costs, and facilitate rapid public health response efforts.

Join us to learn how saliva-based testing can offer a patient-friendly solution with the potential to transform global health outcomes.

Microsampling for plasma cell dyscrasias MPU (300 x 250 px).png

PCSIG Webinar On Demand -
Perceptions and acceptability of microsampling for remote monitoring in patients with plasma cell dyscrasias

Nithya Paranthaman
(Senior Scientific Officer, The Royal Marsden Hospital)​


In this webinar, we discuss the importance of involving patients in our research and the valuable insight we have been able to gain.

​

Multiple myeloma is categorized as a relapsing-remitting blood cancer and requires frequent blood tests. Microsampling introduces a self-administered, blood sampling technique that has potential to revolutionize multiple myeloma monitoring.

In this presentation, we discuss how we incorporated patient and public involvement (PPI) into our study.

Capillary sampling methods Social Square (1200 x 1200 px).png

PCSIG Webinar On Demand - 
Unlocking the future of blood collection: a step-by-step guide for the performance assessment of capillary sampling methods

Vincent Molenaar (PhD candidate and Global Market Manager Alternative Sampling, Leiden University Medical Center (NeLL - National eHealth Living Lab) and Greiner Bio-One, The Netherlands)​

 

Verifying alternative capillary sampling methods for the responsible development of decentralized blood collection using a new methodology based on Six Sigma.

As alternative blood sampling methods continue to grow due to phlebotomist shortages and the need for person-centered care, it is vital to support these innovations with solid scientific validation. This webinar introduces the σ3-methodology, a Six Sigma-based approach developed to measure and verify the accuracy and precision of alternative blood sampling methods like lateral upper-arm blood collection (LUBC). Watch to explore this methodology, learn about its clinical impact, and understand how it can enhance diagnostic care by enabling safe and effective decentralized sample collection at home.

Microsampling for serosurveillance in Kenya Social Square (1200 x 1200 px) (1).png

PCSIG Webinar On Demand -
Acceptability and validity of microsampling for serosurveillance in Kenya

Makobu Kimani (Post-doctoral clinical epidemiologist, KEMRI-Wellcome Trust Research Program) and Rose Ombati (Research Officer, KEMRI-Wellcome Trust Research Program)

In this webinar we present findings from a study assessing the acceptability, ease of use and validity of two microsampling techniques against venous blood sampling. This was a pilot study nested within a multi-pathogen serosurveillance project.  In addition, we compare how well the Mitra™ microsampler and traditional Whatman DBS filter paper compare to gold standard venous blood draws. 

Patient Sampling of Capillary Blood Social Square (1200 x 1200 px).png

PCSIG Webinar On Demand - 
Patient sampling of capillary blood provides unique biological insights into autoimmune flares

Tatyana Dobreva (Chief Executive Officer & Co-Founder, ImYoo)

In this webinar, ImYoo will present preliminary data on biological insights derived from their decentralized autoimmune flare study. Specifically, they will highlight cell-specific transcript markers identified through longitudinal sampling of flares in inflammatory bowel disease and rheumatoid arthritis – markers often overlooked in cross-sectional study designs. ImYoo will further explore how its decentralized approach to collecting substantial molecular data enhances patient diversity, compliance, and retention in studies.

PCSIG PFAS in Blood Social Square (1200 x 1200 px).png

PCSIG Webinar On Demand -
Advancing the collection and analysis of PFAS in blood

Andrew Patterson (VP of Innovation and Development, Specialty Services, Eurofins Environment, North America)

Recently, the National academies of Sciences, Engineering and Medicine (NASEM) has recommended that people test their water and blood for per- and polyfluorinated substances (PFAS). Traditionally, PFAS tests have been conducted with serum. Only recently has technology developed to a point where both a volumetric sampling device and highly sensitive instrumentation can come together to assist the analytical challenge of a remote PFAS blood test. Equally important are the suite of isotopically labelled standards that are spiked into every sample to aid in quantitation. This approach is known as isotope dilution and it is considered the gold-standard of quantitation.

This talk aims to educate the viewer on this new approach for PFAS testing.

PCSIG Wbinar_Feb2024.png

PCSIG Webinar On Demand -
How can a drop of blood be used for elemental analysis?

Speaker: Ciprian Mihai Cirtiu (Supervisor of Trace Metals Team, Centre de toxicologie du Québec – Institut national de santé publique du Québec, Canada)

Clinical dosage of toxic and essential elements in blood is well established; however, the collection method nowadays is still by venipuncture. This method has several drawbacks and is not suited for everyone, especially pediatric patients. Fortunately, volumetric absorptive microsampling (VAMS®) has been shown to bring significant advantages over venipuncture for blood sampling.

This webinar provides an overview of the development and validation as well as the performance of a method for the quantification by ICP-MS/MS of various toxic and essential elements in blood collected on VAMS tips.

PCSIG Webinar_Jan2024_2.png

PCSIG Webinar On Demand -
Analytical considerations, tips and tricks for quantitative analysis of patient-centric samples and microsamples

Speaker: Mitch Johnson (Lab Director, Veloxity Labs)

Discussion of method development and validation, sample handling, additional experimental considerations for patient-centric sampling.

Microsampling and patient-centric sampling is a relatively new and emerging field that has been introduced with success in both the preclinical and clinical space. Although there have been significant advancements made on the collection side, there remains challenges and considerations on the lab side of things. This talk will touch on additional experimental considerations and tips for processing and handling samples.​​​​​​​

PCSIG Webinar_Dec2023.png

PCSIG Webinar On Demand -
Finger-prick sampling for the monitoring of tacrolimus, creatinine and hemoglobin in kidney transplant recipients

Speakers: Nils Tore Vethe (Head of Section, Department of Pharmacology, Oslo University Hospital) and Karsten Midtvedt (Senior Physician in Nephrology, Department of Transplantation Medicine, Oslo University Hospital)

Finger-prick sampling emerges as an attractive tool for therapeutic drug monitoring and associated diagnostics during follow-up in different patient populations. Kidney transplant recipients constitute a group with likely valuable gain from this concept. It is necessary to meet requirements for quality, efficiency, user-friendliness and new forms of interaction in order to achieve successful implementation in clinical practice. Aspects related to technical operations and quality, factors important for success, as well as identified challenges will be highlighted in this webinar.

PCSIG Webinar Sept2023.png

PCSIG Webinar On Demand -
Microsampling: what do we need to do to accelerate the real-life uptake?

Speaker: Christophe Stove (Ghent University)

This presentation provides an overview of the distinct requirements for routine implementation of dried blood microsampling.

PCSIG_2.png

PCSIG Webinar On Demand -
Transforming Healthcare Using Big Data and Remote Monitoring

Speaker: Michael Snyder (Professor & Chair, Stanford University School of Medicine)

Join in this Free Webinar to learn about the use of big data and remote monitoring to transform healthcare today. Moderated by Neil Spooner, Director, Spooner Bioanalytical Solutions and Co-Founder of the PCSIG.

​

PCSIG_1.png

PCSIG Webinar On Demand -
Patient centric sampling in pediatric clinical trials – successes, challenges and how to overcome them

Speakers: Enaksha Wickremsinhe (Senior Director, Eli Lilly & Company) and Jeff Silverman (Senior Research Fellow, Edgewise Therapeutics)

This Free Webinar discusses the use of patient centric sampling technologies for the collection of high quality blood samples for pediatric clinical trials.

Moderated by Neil Spooner, Director, Spooner Bioanalytical Solutions and Co-Founder of the Patient Centric Sampling Interest Group (PCSIG),

bottom of page